LAUREN BOHLEY: Open Payments
NPI 1548228760 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 40 payments from 12 companies in 2025. Trend: 2023 $784 · 2024 $1,038 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $206 |
| Dexcom, Inc. | 3 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Exact Sciences Corporation | 3 | $71 |
| Boston Scientific Corporation | 2 | $70 |
| Amgen Inc. | 4 | $60 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| PFIZER INC. | 3 | $46 |
| Lilly USA, LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
Products named: Dexcom G6 Transmitter, QULIPTA, UBRELVY, Cologuard Collection Kit, WATCHMAN FLX, NURTEC ODT, REPATHA, FARXIGA.
Industry payments across PA — which companies pay providers there.
